IV therapy clinic marketing: claims, compounding and ad rules

IV therapy menus often read like wellness products: drips named for energy, recovery, beauty or immunity. Under federal law and ad platform policy, though, many of these services involve prescription drugs, and some involve compounded drugs. That changes what you can say on your website, in ads and on social media.

This guide covers the marketing rules for IV hydration bars, med spas, mobile IV services and practices that offer vitamin injections. It does not discuss which treatments are appropriate for anyone, ingredients, doses or clinical protocols. Those are decisions for licensed clinicians under your state’s laws. When an ad names a prescription drug or a compounded product, see our guide to advertising a prescription treatment under FDA and FTC rules. For the pharmacy side of compounding, see our guide to compounding pharmacy marketing. For sauna studios and heat sessions, see our guide to infrared sauna marketing claims. For “lipo” shots and injections sold to dissolve fat, see our guide to fat-dissolving injection marketing. Clinics that also offer ozone treatments should read our guide to ozone therapy marketing rules. Peptide offers face FDA bulk drug substance rules; see peptide therapy clinic marketing.

Health claims need scientific evidence

The FTC Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require substantiation in the form of competent and reliable scientific evidence. It adds that, as a general matter, this means randomized, controlled human clinical testing. The guidance covers dietary supplements and other health-related products, and says FTC law makes no bright-line distinctions between categories of health-related products or claims.

Implied claims count too. The FTC gives the example of an ad that says a supplement boosts the immune system during winter and shows people sneezing and coughing. It says that ad likely tells consumers the product helps prevent colds, so the advertiser must be able to support a cold prevention claim even though the ad never mentions a disease.

For an IV menu, that means a drip named for immunity, hangovers, detox or recovery is making a health claim through its name, pictures and copy. Before you publish one, ask what the name tells a reasonable reader and whether your practice holds clinical evidence for that exact claim, for that formulation, in the way you deliver it.

• Describe what a service is, who performs it and what a visit involves, rather than what it will do for the reader.
• Avoid names and images that imply prevention or treatment of a disease you cannot support.
• Do not borrow studies about a different ingredient, route or amount. The FTC says research on a different formulation may not support your product.
• Keep clinical questions, such as whether a drip is right for a specific person, with your clinicians.

Compounded drugs are not FDA approved

Many IV and injection services use drugs prepared by a compounding pharmacy or an outsourcing facility. FDA says plainly that compounded drugs are not FDA-approved, which means FDA does not verify their safety, effectiveness or quality before they are marketed. FDA also says compounded drugs and generic drugs are not the same: a generic is approved by FDA, while a compounded drug is not.

So your marketing should never call a compounded product FDA approved, describe it as a generic, or say it is the same as an approved drug. FDA also states that prescription drug promotion disseminated by or on behalf of drug manufacturers, including compounders, must be truthful, non-misleading and accurate.

FDA describes two federal pathways. Under section 503A of the Food, Drug, and Cosmetic Act, a state-licensed pharmacist or a physician compounds a drug for an individual patient based on a prescription. Under section 503B, outsourcing facilities compound drugs under current good manufacturing practice requirements and are inspected by FDA on a risk-based schedule. If your supplier is a registered outsourcing facility, you can say so accurately, but registration and inspection are not FDA approval of the drug, and your wording should not suggest otherwise.

FDA also notes that poor compounding practices can cause serious quality problems, such as contamination or the wrong amount of active ingredient. That is a reason to be careful with words like safe, pure or pharmaceutical grade unless you can document exactly what they mean for your supplier.

Vitamin injection bars and wellness shots

Some IV clinics, med spas and standalone shot bars also sell vitamin injections from a menu, often as a walk-in service, with names such as energy, immunity, beauty or slim. Everything above about evidence, compounding and reviews applies to these shots too. Two more federal provisions matter before you write the menu.

Prescription status is set by law and shown on the label. Under 21 USC 353(b)(1), a drug that “because of its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use, is not safe for use except under the supervision of a practitioner licensed by law to administer such drug” may be dispensed only on a prescription, and dispensing it otherwise makes the drug misbranded. Under 21 USC 353(b)(4)(A), the label of such a drug must bear, at a minimum, the symbol “Rx only”. The simplest check is the vial or carton: if it says “Rx only”, your menu is selling a prescription drug, whatever the shot is called.

That shapes the wording. “Walk in, no prescription needed” for a product labeled “Rx only” promises exactly what 21 USC 353(b)(1) rules out. Describe the step your practice really uses, such as a review by a licensed prescriber before the first injection, using the roles your state allows.

Compounded shots are made for identified patients. 21 USC 353a(a) applies its exemptions only when a drug product “is compounded for an identified individual patient based on the receipt of a valid prescription order”, or in limited quantities before a prescription arrives, based on a history of valid prescription orders. A menu that sells a compounded shot to anyone who walks in, with no patient-specific order behind it, does not match how the statute describes compounding. How orders flow between your prescribers and a 503A pharmacy or 503B outsourcing facility is a question for your pharmacist and attorney; the page should not describe the product in a way your supply chain does not support.

An old advertising ban you may still see quoted. 21 USC 353a used to say a compounder could not “advertise or promote the compounding of any particular drug, class of drug, or type of drug.” The Drug Quality and Security Act (Pub. L. 113-54, November 27, 2013) struck that subsection out, according to the amendment notes to the section. Advertising a compounded shot is not barred by 353a today, but the FDA statements earlier in this guide still apply: never call a compounded shot FDA-approved, a generic or the same as an approved drug.

Shot names are claims. The FTC Act declares “unfair or deceptive acts or practices in or affecting commerce” unlawful (15 USC 45(a)(1)) and makes it unlawful to disseminate a false advertisement to induce the purchase of drugs or services (15 USC 52). An energy, immunity, metabolism or detox shot makes a health claim through its name, held to the same evidence standard as a drip name. A slim, skinny or fat-burning shot is a weight loss claim; our guide to weight loss clinic marketing covers those rules.

• Check every injectable product’s label for “Rx only” before writing menu copy.
• Name shots plainly, by what they contain, rather than by a promised effect.
• Never advertise “no prescription needed” for a product labeled “Rx only”.
• Never call a compounded shot FDA-approved, generic or the same as an approved drug.
• Hold each stated or implied benefit to the same evidence standard as your drips.

Ad platforms treat many IV services as prescription drug services

Google restricts the promotion of services related to the online prescribing, dispensing and sale of prescription drugs, and names online pharmacies and telemedicine providers as examples. Advertisers must apply and be certified to serve ads for prescription drug services, and certification rules vary by location. Google also restricts prescription drug terms in ads, landing pages and keywords. Its unauthorized pharmacies policy says offering prescription drugs without a prescription is not allowed.

Google’s unapproved substances policy separately does not allow non-government approved products marketed in a way that implies they are safe or effective for preventing, curing or treating a disease, or products that imply they are as effective as prescription drugs. Wellness claims on a drip landing page can trigger review even when the ad text itself is plain.

Meta allows ads that promote prescription drugs only from eligible advertisers. Its policy says online pharmacies and telehealth providers must be actively certified with LegitScript and then request authorization from Meta, and that such ads may only target people 18 or older. Meta’s health and wellness policy also requires ads for health products and services in its listed categories to target people at least 18 years old.

In practice, plan your campaigns around the visit and the provider, check whether your exact service needs certification before you launch, and expect drip names that mention diseases or symptoms to be rejected. Our Google Ads management for practices starts with that policy check, and healthcare ad policy basics covers the wider rules.

Reviews, testimonials and results

Under 16 CFR 255.2, an endorsement that conveys a performance claim is treated as a claim by the advertiser, which needs the same substantiation, and an advertiser may need to disclose the generally expected results when an endorser’s experience is not typical. The FTC guidance gives an example of customer testimonials about a sleep app and says testimonials do not constitute substantiation.

So a client post saying a drip cured their migraine or ended their cold is a claim your practice would have to support. Do not repost it in ads or on service pages. Ask for reviews about the visit itself: booking, wait time, comfort and how clearly the team explained things. Our guide to patient testimonials and before-and-after photos covers consent and the FTC rules in more detail.

Mobile IV, telehealth intake and who is responsible

Mobile and telehealth models raise questions patients ask before they book: who reviews my health history, who places the IV, and who do I call if something goes wrong. Answer those on the site in plain words, using the roles your practice actually has. State law decides who may assess, order and administer, so describe your own process rather than a general one, and do not list a medical director, nurse or credential you cannot document.

If you take health history online, keep that form separate from marketing tools. Our guides to online patient intake forms and tracking pixels on practice websites explain why.

Pricing, memberships and packages

Drip menus usually show prices, and many clinics sell memberships or packages. State the price, what it includes and any add-ons clearly, and make sure the site, ads and phone give the same answer. If you offer payment plans, read advertising payment plans and patient financing before you put a monthly figure in an ad. A clear treatment page for each service, built as part of your med spa marketing or practice website, gives ads a relevant place to land.

A checklist before you publish an IV menu

1. Names and images: does any drip name, photo or emoji imply preventing or treating a disease?
2. Evidence: for every benefit stated or implied, does your practice hold competent and reliable scientific evidence for that formulation?
3. Compounding wording: no FDA approved, generic or same as language for compounded products.
4. Prescriptions: does the page make clear a clinician assesses each person, without offering prescription drugs without a prescription?
5. Ad accounts: have you confirmed whether your service needs Google certification or LegitScript and Meta authorization, and set 18+ targeting where required?
6. Reviews: no outcome testimonials reused in ads or on service pages.
7. People: every role and credential on the page is real and documented.
8. Shots: every injectable checked for “Rx only” on its label, with no “no prescription needed” wording for those products (21 USC 353(b)).

Frequently asked questions

Sources

• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 255.2: Consumer endorsements
• FDA: Compounding and the FDA, Questions and Answers (content current as of September 16, 2025)
• FDA: Clarifies policies for compounders, 503A and 503B conditions (updated April 1, 2026)
• Google Ads: Healthcare and medicines policy
• Google Ads: Prescription drug services policy
• Meta: Drugs and pharmaceuticals ad policy
• Meta: Health and wellness ad policy
• 21 USC 353(b): Prescription drugs
• 21 USC 353a: Pharmacy compounding (with 2013 amendment notes)
• 15 USC 45: Unfair methods of competition unlawful
• 15 USC 52: Dissemination of false advertisements

More in Cash-pay, aesthetic and wellness care